BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32911601)

  • 21. Identification of clinical risk factors for histological progression of primary biliary cholangitis.
    Fujinaga Y; Namisaki T; Moriya K; Kitade M; Kawaratani H; Shimozato N; Kaji K; Takaya H; Sawada Y; Seki K; Akahane T; Okura Y; Sato S; Saikawa S; Nakanishi K; Kubo T; Furukawa M; Kitagawa K; Ozutsumi T; Tsuji Y; Kaya D; Mashitani T; Ishida K; Ogawa H; Takagi H; Noguchi R; Mitoro A; Yamao J; Yoshiji H
    Hepatol Res; 2019 Sep; 49(9):1015-1025. PubMed ID: 31021038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive antimitochondrial antibody but normal serum alkaline phosphatase levels: Could it be primary biliary cholangitis?
    Berdichevski T; Cohen-Ezra O; Pappo O; Ben-Ari Z
    Hepatol Res; 2017 Jul; 47(8):742-746. PubMed ID: 27572231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Transferrin Isoforms in Pancreatic Cancer.
    Gruszewska E; Cylwik B; Gudowska M; Kedra B; Szmitkowski M; Chrostek L
    Ann Clin Lab Sci; 2016 May; 46(3):286-90. PubMed ID: 27312554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extrahepatic Manifestations of Primary Biliary Cholangitis.
    Chalifoux SL; Konyn PG; Choi G; Saab S
    Gut Liver; 2017 Nov; 11(6):771-780. PubMed ID: 28292174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced biliary excretion of canalicular membrane enzymes in estrogen-induced and obstructive cholestasis, and effects of different bile acids in the isolated perfused rat liver.
    Accatino L; Figueroa C; Pizarro M; Solís N
    J Hepatol; 1995 Jun; 22(6):658-70. PubMed ID: 7560859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
    Fujino H; Tanaka M; Imamura M; Morio K; Ono A; Nakahara T; Murakami E; Kawaoka T; Takahashi S; Miki D; Tsuge M; Hiramatsu A; Aikata H; Hayes CN; Chayama K
    BMC Gastroenterol; 2019 Oct; 19(1):169. PubMed ID: 31651244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.
    Seki A; Ikeda F; Miyatake H; Takaguchi K; Hayashi S; Osawa T; Fujioka SI; Tanaka R; Ando M; Seki H; Iwasaki Y; Yamamoto K; Okada H
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1611-1616. PubMed ID: 28114749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Serum Profile of Transferrin Isoforms in Pancreatitis.
    Mucha A; Zaczek M; Kralisz M; Gruszewska E; Cylwik B; Panasiuk A; Chrostek L
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?
    Sun C; Xiao X; Yan L; Sheng L; Wang Q; Jiang P; Lian M; Li Y; Wei Y; Zhang J; Chen Y; Li B; Li Y; Huang B; Li Y; Peng Y; Chen X; Fang J; Qiu D; Hua J; Tang R; Leung P; Gershwin ME; Miao Q; Ma X
    J Autoimmun; 2019 May; 99():33-38. PubMed ID: 30709684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics.
    Patel A; Seetharam A
    J Clin Exp Hepatol; 2016 Dec; 6(4):311-318. PubMed ID: 28003721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
    Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
    [No Abstract]   [Full Text] [Related]  

  • 33. CTHRC1 expression in primary biliary cholangitis.
    Li YK; Li YM; Li Y; Wei YR; Zhang J; Li B; You ZR; Chen Y; Huang BY; Miao Q; Wang QX; Peng YS; Gershwin ME; Tang RQ; Bian ZL; Ma X
    J Dig Dis; 2019 Jul; 20(7):371-376. PubMed ID: 31102333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis.
    Li Y; Li B; You Z; Zhang J; Wei Y; Li Y; Chen Y; Huang B; Wang Q; Miao Q; Peng Y; Fang J; Gershwin ME; Tang R; Greenberg SA; Ma X
    J Autoimmun; 2019 Sep; 103():102293. PubMed ID: 31255417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
    van de Meeberg PC; Wolfhagen FH; Van Berge-Henegouwen GP; Salemans JM; Tangerman A; van Buuren HR; van Hattum J; van Erpecum KJ
    J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.
    Sherlock S
    Clin Liver Dis; 2000 Feb; 4(1):97-113. PubMed ID: 11232193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical serum transferrin isoform distribution in liver cirrhosis studied by HPLC, capillary electrophoresis and transferrin genotyping.
    Arndt T; van der Meijden BB; Wielders JP
    Clin Chim Acta; 2008 Aug; 394(1-2):42-6. PubMed ID: 18442477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Update on the Treatment and Follow-up of Patients with Primary Biliary Cholangitis.
    Burman BE; Jhaveri MA; Kowdley KV
    Clin Liver Dis; 2017 Nov; 21(4):709-723. PubMed ID: 28987258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis.
    Lim AG; Jazrawi RP; Ahmed HA; Levy JH; Zuin M; Douds AC; Maxwell JD; Northfield TC
    Hepatology; 1994 Oct; 20(4 Pt 1):882-8. PubMed ID: 7927229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat.
    Accatino L; Pizarro M; Solís N; Koenig CS; Vollrath V; Chianale J
    J Hepatol; 1996 Sep; 25(3):349-61. PubMed ID: 8895015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.